Timeline
The Premarket Brief: LBG Media cuts earnings guidance on Meta algorithm hit, Vantiva HomeSight, Imaging Biometrics, GSK, Keller
Fevertree remains confident of matching market expectations as it extends buyback
GSK to buy Nuvalent for $10.6bn to add late‑stage lung‑cancer drugs
Small Caps Today: Verici Dx, Neo Energy Metals, Brickability, Beeks, SkinBio Therapeutics ...
The Premarket Brief: Seraphim Space to join FTSE 250 after £137m raise, Neo Energy CFO suspended, BRCK Group, Pensana, Mpac Group ...
Seraphim Space Investment Trust to join FTSE 250 on 19 June
Helium One sees first offtake for Galactica’s Pinon Canyon output
Cordiant Digital Infrastructure added to FTSE 250
The Premarket Brief: ITM Power and Protium partner on UK hydrogen, Currys, B&M, Boohoo
Currys names Fredrik Tønnesen as its new Group Chief Executive
British American Tobacco says its on track as new product categories accelerate
Mining Today: Bluebird Mining's South Korea royalty deal, Aterian, First Class Metals, Forgent, Lexington Gold, Greatland Gold
Greatland Gold dips as debt facility and Havieron FID milestone reached
Health & Bio Today: CelLBxHealth wins AstraZeneca services deal, Avacta Group, AstraZeneca
CelLBxHealth shares rocket on AstraZeneca master services agreement
Small Caps Today: CelLBxHealth signs AstraZeneca services deal, Europa Oil & Gas, Tooru, Fandango, Itaconix, MedPal A and more
The Premarket Brief: CelLBxHealth signs AstraZeneca services deal, Tooru, Clean Power Hydrogen, Ocado
AstraZeneca wins US approval for Imfinzi in early high‑risk bladder cancer
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
GSK posts positive Phase 3 results for Hepatitis B treatment
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca,
Harworth adds Barclays to £275m RCF syndicate
The Premarket Brief: Sound Energy sells Tendrara stake for $57m, CVS Group, Arrow Exploration, AstraZeneca, Atalaya Mining
AstraZeneca wins CHMP backing for Enhertu tumour‑agnostic approval
JD Sports Fashion publishes inaugural FY26 Global Impact Report
Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca
IG Group upgrades 2026 revenue guidance after strong Q1
Burberry's a Buy with its investment case intact
GSK lands expanded approval for RSV vaccine Arexvy in Japan
AstraZeneca secures US approval for blood pressure drug Baxfendy
The Premarket Brief: Vistry flags significantly lower first-half profit, Marshalls, NatWest, TP ICAP, Babcock
Spirax Group sticks to guidance as first four months land in line with expectations
Gamma Communications expects FY 2026 to be in line with market expectations
EnergyPathways and ABP to assess Port of Barrow for MESH onshore facilities
Gamma confirms Providence among parties in takeover talks
Fitch upgrades NatWest Group subsidiaries to 'AA'
Greggs is handling the heat in the kitchen well analyst says
Greggs keeps full-year outlook after sales rise
The Premarket Brief: Marston's reaffirms FY2026 guidance on margin gains, Angling Direct, Greggs, Wickes, Novo Nordisk, Wizz Air
Tan Delta Systems wins £395,000 order from major engine OEM
Compass Group raises 2026 profit guidance after strong half
GSK strikes exclusive China collab to roll out bepirovirsen
Greatland sees high grade gold in exploration drilling
Barclays completes £1bn buy-back and starts new £500m programme
Shell Q1 earnings eclipse expectations at $6.9bn, campaigners cry war 'windfall'
BAE Systems maintains 2026 guidance as orders and buybacks continue
JD Sports sets FY27 profit and cash guidance after resilient FY26
Diageo is showing tentative signs of stabilisation says analyst
More in Markets
The Premarket Brief: Apollo eyes all-cash easyJet takeover, Hays, Gleeson, Avingtrans
Apollo Global Management has put easyJet in play with a possible all-cash takeover approach. Elsewhere, there's a staffing update from Hays, a housebuilder result from MJ Gleeson, and a £21m fundraise from Avingtrans.